Entrada Therapeutics (TRDA) Assets (2020 - 2026)
Entrada Therapeutics (TRDA) posted Assets of $298.88 million for Q2 2026, down 33.4% from $448.78 million a year earlier and down 10.9% from the prior quarter.
Entrada Therapeutics (TRDA) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics' Assets came in at $377.38 million, down 28.3% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of 54.0% (FY2020 to FY2025).
- In prior years, Entrada Therapeutics' Assets was $526.32 million in FY2024 (+12.2%), $469.19 million in FY2023 (+86.1%), $252.06 million in FY2022 (-17.6%) and $305.83 million in FY2021 (+602.6%).
- The Q2 2026 figure stands as the lowest quarterly Assets since Q4 2022.
- On a year-over-year basis, Assets has declined in each of the last six quarters, with an average decline of 14.9% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q4 2021, with growth of 602.6%; the weakest was Q2 2026, with a decline of 33.4%.
- According to Business Quant data, Assets for the three prior quarters was $335.52 million (Q1 2026), $377.38 million (Q4 2025) and $412.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | 298.88 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 298.88 Mn |
| Mar 31, 2026 | 335.52 Mn |
| Dec 31, 2025 | 377.38 Mn |
| Sep 30, 2025 | 412.90 Mn |
| Jun 30, 2025 | 448.78 Mn |
| Mar 31, 2025 | 486.48 Mn |
| Dec 31, 2024 | 526.32 Mn |
| Sep 30, 2024 | 554.59 Mn |
| Jun 30, 2024 | 581.96 Mn |
| Mar 31, 2024 | 510.84 Mn |
| Dec 31, 2023 | 469.19 Mn |
| Sep 30, 2023 | 485.03 Mn |
| Jun 30, 2023 | 493.98 Mn |
| Mar 31, 2023 | 475.57 Mn |
| Dec 31, 2022 | 252.06 Mn |
| Sep 30, 2022 | 274.46 Mn |
| Jun 30, 2022 | 295.92 Mn |
| Mar 31, 2022 | 316.70 Mn |
| Dec 31, 2021 | 305.83 Mn |
| Sep 30, 2021 | 132.40 Mn |
Entrada Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();